New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...

Quote Panel

Shape
Updated May 9, 2025
1W 0.03 % 1M 1.58 % 3M 0.09 % 1Y 0.61 %

Key Metrics

Shape
  • Market Cap

    26.40M


  • Shares Outstanding

    758426


  • Share in Float


  • Dividende

    2.1062


  • Earning Date

    No Data


  • Price Target

    34.8152


  • Average Volume

    1137


  • Beta

    0.27655354


  • Range

    33.92-37.24


  • Industry

    Biotechnology


  • Website

    http://www.eyegatepharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

EYEG

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

N/A

-0.71
vs -0.75

Q1.20

arrow
arrow

N/A

-0.43
vs 0.15

Q2.20

arrow
arrow

N/A

-0.38
vs -0.60

Q3.20

arrow
arrow

N/A

-0.44
vs -1.15

Q4.20

arrow
arrow

N/A

-0.52
vs -0.71

Q1.21

arrow
arrow

N/A

-0.37
vs -0.43

Q2.21

arrow
arrow

N/A

-0.35
vs -0.38

Q3.21

arrow
arrow

N/A

-0.42
vs -0.44

Q2.24

arrow
arrow

N/A

-0.53
vs NA

Q3.24

arrow
arrow

N/A

-0.81
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

NA

NA  vs NA

Q1.20

arrow
arrow

-100%

NA  vs 2.7M

Q2.20

arrow
arrow

NA

NA  vs NA

Q3.20

arrow
arrow

NA

NA  vs NA

Q4.20

arrow
arrow

NA

12.1K  vs NA

Q1.21

arrow
arrow

NA

NA  vs NA

Q2.21

arrow
arrow

NA

NA  vs NA

Q3.21

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

20K  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q2.20

arrow
arrow

-22%

-0.22
vs -0.21

Q3.20

arrow
arrow

-34%

-0.34
vs -0.22

Q4.20

arrow
arrow

-35%

-0.35
vs -0.34

Q1.21

arrow
arrow

-20%

-0.20
vs -0.35

Q2.21

arrow
arrow

-24%

-0.24
vs -0.20

Q3.21

arrow
arrow

-17%

-0.17
vs -0.24

Q2.24

arrow
arrow

-7%

-0.07
vs -0.17

Q3.24

arrow
arrow

-11%

-0.11
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q4.19

arrow
arrow

14

14
vs 9

56%

Q1.20

arrow
arrow

12

12
vs 14

-14%

Q2.20

arrow
arrow

10

10
vs 12

-17%

Q3.20

arrow
arrow

11

11
vs 10

10%

Q4.20

arrow
arrow

12

12
vs 11

9%

Q1.21

arrow
arrow

16

16
vs 12

33%

Q2.21

arrow
arrow

17

17
vs 16

6%

Q3.21

arrow
arrow

19

19
vs 17

12%

Earnings Growth

Latest News